Biopharm Business - BioPharm International


Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

M&A Activity in Pharma Still Strong Despite New Tax Rules

November 4, 2014

M&A transactions accounted for nearly $15 billion more this year than for the same period a year ago.

AbbVie/Shire Deal Officially Off

October 20, 2014

AbbVie to pay Shire $1.636 billion break fee for terminating purchase agreement.

GSK Fined in China Bribery Scandal

September 19, 2014

GSK is found guilty of offering bribes to doctors and is fined $489 million.

Biotech Industry Forms International Council

July 10, 2014

New International Council on Biotechnology Associations advocates biotechnology growth.

NIH and NSF Collaborate on Biomedical Innovation

June 18, 2014

The National Institutes of Health and the National Science Foundation set up biomedical innovation and business program.

Global Instability Affects the Pharma Market in Brazil

April 1, 2014

How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?

Report: Branded Biopharms Most Exposed to Biosimilar Competition

February 26, 2014

Moody's Investor Service reports AbbVie, Amgen, and Roche are the most exposed to biosimilar competition.

Lilly Acquires CGRP Antibody from Arteaus Therapeutics

January 20, 2014

Eli Lilly acquires development rights for CGRP antibody as a potential treatment for migraines.

Genmab Collaborates With Lilly On DuoBody Platform

January 20, 2014

Genmab enters collaboration with Eli Lilly to use and evaluate Genmab's DuoBody technology for bispecific antibodies.



Click here